These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 5163492)
1. [Research on neoplastic antigens]. De Barbieri A; Tassi GC Boll Ist Sieroter Milan; 1971; 50(4):243-50. PubMed ID: 5163492 [No Abstract] [Full Text] [Related]
2. [Clinical results in cancer patients treated with an original technic of active immunotherapy]. Alem C Boll Ist Sieroter Milan; 1971; 50(4):260-7. PubMed ID: 5163493 [No Abstract] [Full Text] [Related]
3. Basic principles of the immune response and the immunologic inhibition of tumors. Vorlaender KO Allergol Immunopathol (Madr); 1973 Jul; 1(4):235-46. PubMed ID: 4794103 [No Abstract] [Full Text] [Related]
4. [Modern aspects of tumor immunology]. Warnatz H Med Welt; 1978 Oct; 29(41):1616-20. PubMed ID: 692357 [No Abstract] [Full Text] [Related]
6. [Immunologic factors relating to tumor growth and dissemination]. Alexander P Maroc Med; 1972 Oct; 52(561):565-70. PubMed ID: 4667466 [No Abstract] [Full Text] [Related]
7. [Immunological problems in oncology]. Gazzera G G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1971; 64(1):37-80. PubMed ID: 5158566 [No Abstract] [Full Text] [Related]
8. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies. Bodey B; Siegel SE; Kaiser HE Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112 [TBL] [Abstract][Full Text] [Related]
9. [Specific active immunotherapy of cancer]. Valladares Y An R Acad Nac Med (Madr); 1982; 99(1):109-46. PubMed ID: 6181704 [No Abstract] [Full Text] [Related]
10. Disialoganglioside GD2 and a novel tumor antigen: potential targets for immunotherapy of desmoplastic small round cell tumor. Modak S; Gerald W; Cheung NK Med Pediatr Oncol; 2002 Dec; 39(6):547-51. PubMed ID: 12376975 [TBL] [Abstract][Full Text] [Related]
11. [Immunological aspects of tumor pathology]. Piacentini G; Ferrari S Boll Ist Sieroter Milan; 1971; 50(3):199-208. PubMed ID: 5146577 [No Abstract] [Full Text] [Related]
12. Principles and use of anti-CTLA4 antibody in human cancer immunotherapy. Peggs KS; Quezada SA; Korman AJ; Allison JP Curr Opin Immunol; 2006 Apr; 18(2):206-13. PubMed ID: 16464564 [TBL] [Abstract][Full Text] [Related]
13. [Immunochemical studies on tumors]. Grabar P Arq Patol; 1969 Aug; 41(2):239-50. PubMed ID: 5403873 [No Abstract] [Full Text] [Related]
16. About human tumor antigens to be used in immunotherapy. Lucas S; Coulie PG Semin Immunol; 2008 Oct; 20(5):301-7. PubMed ID: 18395462 [TBL] [Abstract][Full Text] [Related]
17. [Abnormal antigen determined immunoelectrophoretically in various malignant diseases]. Munzarová M; KubĂcek R; Trnka A Vnitr Lek; 1976 Feb; 22(2):174-8. PubMed ID: 1258405 [No Abstract] [Full Text] [Related]
18. Valence and association constant of rat macroglobulin antibody. Oriol R; Binaghi R; Coltorti E J Immunol; 1971 Apr; 106(4):932-7. PubMed ID: 5553719 [No Abstract] [Full Text] [Related]
19. Immunotherapy of cancer with "immune" RNA: current status. Pilch YH; deKernion JB Semin Oncol; 1974 Dec; 1(4):389-95. PubMed ID: 4620442 [No Abstract] [Full Text] [Related]
20. [The function of tumor specific antigen (MAGE) in tumor immunotherapy]. Fang JB; Wang L Sheng Li Ke Xue Jin Zhan; 2005 Jul; 36(3):273-5. PubMed ID: 16270835 [No Abstract] [Full Text] [Related] [Next] [New Search]